Polar Asset Management Partners’s Cardio Diagnostics CDIO Stock Holding History

Polar Asset Management Partners’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-857	Closed	-$27.2K	–	1069
2022 Q4	$27.2K	Sell	857 -5,139	-86%	-$555K	﹤0.01%	960
2022 Q3	$1.81M	Hold	5,996	–	–	0.02%	707
2022 Q2	$1.79M	Hold	5,996	–	–	0.02%	711
2022 Q1	$1.78M	Buy	+5,996	New	+$1.77M	0.02%	648

Other funds holding CDIO

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSC

Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Polar Asset Management Partners's CDIO Position: Q1 2023 in Review

Polar Asset Management Partners sold out of Cardio Diagnostics (CDIO) in Q1 2023, closing a stake of 857 shares — an estimated $27.2K sold.

Polar Asset Management Partners first reported a position in CDIO in Q1 2022 and held it in 4 quarters. The position peaked at $1.81M in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q1 2023.

Polar Asset Management Partners reported no remaining Cardio Diagnostics position as of Q1 2023 after selling out during the quarter.
Polar Asset Management Partners sold 857 Cardio Diagnostics shares in Q1 2023, an estimated $27.2K.
Polar Asset Management Partners first reported a position in Cardio Diagnostics in Q1 2022 and held it in 4 quarters.
Polar Asset Management Partners's Cardio Diagnostics position peaked at $1.81M in Q3 2022.
11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.